Phase II clinical trials of WT1 vaccine for post hematopoietic stem cell transplant patients
Phase 2
- Conditions
- Acute leukemia
- Registration Number
- JPRN-UMIN000011780
- Lead Sponsor
- Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
Double cancer Infectious disease Heart failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2year OS PFS
- Secondary Outcome Measures
Name Time Method